APA (7th ed.) Citation

JM, T., DP, F., RM, N., KM, W., LC, d. S., GF, P., . . . G, K. (2023). Dulaglutide as a demethylating agent to improve the outcome of breast cancer. Epigenomics, 15(24), 1309. https://doi.org/10.2217/epi-2023-0332

Chicago Style (17th ed.) Citation

JM, Tatsch, Furman DP, Nobre RM, Wurzer KM, da Silva LC, Picheth GF, Ramos EA, Acco A, and Klassen G. "Dulaglutide as a Demethylating Agent to Improve the Outcome of Breast Cancer." Epigenomics 15, no. 24 (2023): 1309. https://doi.org/10.2217/epi-2023-0332.

MLA (9th ed.) Citation

JM, Tatsch, et al. "Dulaglutide as a Demethylating Agent to Improve the Outcome of Breast Cancer." Epigenomics, vol. 15, no. 24, 2023, p. 1309, https://doi.org/10.2217/epi-2023-0332.